Accipiter Biosciences
Accipiter Biosciences uses computational protein design to develop de novo protein therapies that engage multiple cell-surface receptors and pathways in one stable molecule. Its therapies are designed for complex diseases, including autoimmune disorders and cancer, as an alternative to combination treatments.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 2023 Seattle business license
- Type
- Corporation Seattle business license
- Employees
- 26
- Registered name
- Accipiter Biosciences Inc Seattle business license
- Stage
- Seed
- Members see funding amounts. .
Is this your organization? Claim it
Members see Accipiter Biosciences's funding rounds, amounts and investors.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
See all 4-
Matthew Bick co-founder and Chief Executive Officer
-
Hector Rincon-Arano Co-founder and Chief Scientific Officer
-
Javier Castellanos Co-founder and Chief Technology Officer